This contract was awarded by the Defense Health Agency, a defense agency, to Hamamatsu / Queen's Pet Imaging Center, LLC, a for-profit limited liability company, for the procurement of Fluorine 18 Fluorodeoxyglucose (FDG 18), a Positron Emission Tomography (PET) radiopharmaceutical, to be delivered to the Department of Nuclear Medicine at Tripler Army Medical Center in Hawaii. The contract has a firm fixed-price of $4,072,702.40 and a period of performance through September 30, 2029. This requirement was originally posted as a sources sought notice to determine the availability and capability of qualified sources to fulfill this commercial item acquisition. The contract was not set aside for any specific business category.
Generated 1/17/25, 9:17 AM